Banx Media Platform logo
HEALTHHappening Now

CME to Launch Spot-Quoted XRP and SOL Futures: A New Era for Regulated Crypto Trading

The Chicago Mercantile Exchange (CME) is poised to enhance its crypto offerings by filing to list Spot-Quoted XRP and SOL Futures, with certification expected by November 25, 2025. This move paves the way for regulated, cash-settled futures on two major cryptocurrencies, marking a significant development in the establishment of a structured crypto trading environment.

m

mahn kark

EXPERIENCED
5 min read
38 Views
Credibility Score: 96/100
CME to Launch Spot-Quoted XRP and SOL Futures: A New Era for Regulated Crypto Trading

In a significant development for the cryptocurrency market, the Chicago Mercantile Exchange (CME) has filed to list Spot-Quoted XRP Futures and Spot-Quoted SOL Futures, with the certification date set for November 25, 2025. This strategic move is set to open the floodgates for regulated, cash-settled futures trading in XRP and SOL, two prominent digital assets. Details of the Contracts

The XRP futures contract will consist of 250 units and will utilize the CME CF XRP-USD rate for pricing. Simultaneously, the SOL futures contract will be listed, allowing traders to engage with these digital assets on one of the world's largest and most reputable derivatives markets. Once certified, trading will take place via CME Globex, the CME's electronic trading platform, providing global access to market participants. Significance for the Market

The introduction of these futures contracts signifies a vital step towards establishing more regulated infrastructure in the cryptocurrency space. By offering cash-settled futures, CME aims to enhance market transparency and liquidity, attracting institutional investors who have been cautious about entering the crypto market due to regulatory uncertainties. Conclusion

As more regulated crypto infrastructure is quietly being put in place, the listing of Spot-Quoted XRP and SOL Futures at CME could herald a new era for digital asset trading. This initiative not only fosters a more structured environment for trading cryptocurrencies but also boosts confidence among investors, potentially driving greater participation in the market. The upcoming certification will be closely watched by industry stakeholders, as it could set a precedent for further developments in the regulated crypto space.

Published by Banx Network. This article is part of the Banx decentralized media programme, powered by the BXE token on the XRP Ledger.

Decentralized Media

Powered by the XRP Ledger & BXE Token

This article is part of the XRP Ledger decentralized media ecosystem. Become an author, publish original content, and earn rewards through the BXE token.

Newsletter

Stay ahead of the news — and win free BXE every week

Subscribe for the latest news headlines and get automatically entered into our weekly BXE token giveaway.

No spam. Unsubscribe anytime.

Share this story

Help others stay informed about crypto news

Related articles

Keep exploring the latest stories.

View more
A Weekly Ritual Ended in Blood: Eight Relatives Killed

A Weekly Ritual Ended in Blood: Eight Relatives Killed

A man killed eight relatives during a weekly family dinner, shocking the community and raising questions about domestic violence and mental health.

Revolution Medicines’ Pancreatic Cancer Drug Wins Fast FDA Approval for Expanded Access

Revolution Medicines’ Pancreatic Cancer Drug Wins Fast FDA Approval for Expanded Access

The FDA rapidly authorized expanded access to daraxonrasib, allowing eligible patients with previously treated metastatic pancreatic cancer to receive the expe…

Beneath America's Pharmaceutical Horizon, Global Drugmakers Build New Factories While Science Follows Investment Westward

Beneath America's Pharmaceutical Horizon, Global Drugmakers Build New Factories While Science Follows Investment Westward

Global pharmaceutical companies are committing roughly $500 billion to U.S. manufacturing and research as they expand domestic production capacity.